These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. Moe S; Wazny LD; Martin JE Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients. Kiattisunthorn K; Wutyam K; Indranoi A; Vasuvattakul S Nephrology (Carlton); 2011 Mar; 16(3):277-84. PubMed ID: 21342321 [TBL] [Abstract][Full Text] [Related]
10. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Malberti F; Surian M; Cosci P Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615 [TBL] [Abstract][Full Text] [Related]
16. Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients. Coen G; Mazzaferro S; De Antoni E; Chicca S; DiSanza P; Onorato L; Spurio A; Sardella D; Trombetta M; Manni M Am J Nephrol; 1994; 14(2):106-12. PubMed ID: 8080002 [TBL] [Abstract][Full Text] [Related]
17. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis. Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173 [TBL] [Abstract][Full Text] [Related]
18. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Minisola S; Romagnoli E; Scarnecchia L; Rosso R; Pacitti MT; Scarda A; Mazzuoli G Eur J Endocrinol; 1994 Jun; 130(6):587-91. PubMed ID: 8205259 [TBL] [Abstract][Full Text] [Related]
19. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients. Alghareeb A; Sabry A; Bawadekji H; Alsaran K Ther Apher Dial; 2013 Feb; 17(1):30-4. PubMed ID: 23379490 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial of intermittent versus continuous oral alfacalcidol treatment of hyperparathyroidism in end-stage renal disease. Tarrass F; Yazidi A; Sif H; Zamd M; Benghanem MG; Ramdani B Clin Nephrol; 2006 Jun; 65(6):415-8. PubMed ID: 16792136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]